685 related articles for article (PubMed ID: 33397409)
1. Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments.
Wei X; Chen Y; Jiang X; Peng M; Liu Y; Mo Y; Ren D; Hua Y; Yu B; Zhou Y; Liao Q; Wang H; Xiang B; Zhou M; Li X; Li G; Li Y; Xiong W; Zeng Z
Mol Cancer; 2021 Jan; 20(1):7. PubMed ID: 33397409
[TBL] [Abstract][Full Text] [Related]
2. Epithelial-to-endothelial transition and cancer stem cells: two cornerstones of vasculogenic mimicry in malignant tumors.
Sun B; Zhang D; Zhao N; Zhao X
Oncotarget; 2017 May; 8(18):30502-30510. PubMed ID: 27034014
[TBL] [Abstract][Full Text] [Related]
3. Contribution of cancer stem cells to tumor vasculogenic mimicry.
Yao XH; Ping YF; Bian XW
Protein Cell; 2011 Apr; 2(4):266-72. PubMed ID: 21533771
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of melatonin on hypoxia-induced vasculogenic mimicry via suppressing epithelial-mesenchymal transition (EMT) in breast cancer stem cells.
Maroufi NF; Amiri M; Dizaji BF; Vahedian V; Akbarzadeh M; Roshanravan N; Haiaty S; Nouri M; Rashidi MR
Eur J Pharmacol; 2020 Aug; 881():173282. PubMed ID: 32580038
[TBL] [Abstract][Full Text] [Related]
5. Regulatory mechanisms and therapeutic targeting of vasculogenic mimicry in hepatocellular carcinoma.
Zheng N; Zhang S; Wu W; Zhang N; Wang J
Pharmacol Res; 2021 Apr; 166():105507. PubMed ID: 33610718
[TBL] [Abstract][Full Text] [Related]
6. The hypoxia-related signaling pathways of vasculogenic mimicry in tumor treatment.
Li S; Meng W; Guan Z; Guo Y; Han X
Biomed Pharmacother; 2016 May; 80():127-135. PubMed ID: 27133049
[TBL] [Abstract][Full Text] [Related]
7. Vasculogenic mimicry and tumor metastasis.
Zhang J; Qiao L; Liang N; Xie J; Luo H; Deng G; Zhang J
J BUON; 2016; 21(3):533-41. PubMed ID: 27569069
[TBL] [Abstract][Full Text] [Related]
8. [Research progress in vasculogenic mimicry in
multiple tumors].
Bai J; Xu Z; Liao C; Yang L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 42(3):357-364. PubMed ID: 28364113
[TBL] [Abstract][Full Text] [Related]
9. Advanced research on vasculogenic mimicry in cancer.
Qiao L; Liang N; Zhang J; Xie J; Liu F; Xu D; Yu X; Tian Y
J Cell Mol Med; 2015 Feb; 19(2):315-26. PubMed ID: 25598425
[TBL] [Abstract][Full Text] [Related]
10. Vasculogenic Mimicry in Breast Cancer: Clinical Relevance and Drivers.
Morales-Guadarrama G; García-Becerra R; Méndez-Pérez EA; García-Quiroz J; Avila E; Díaz L
Cells; 2021 Jul; 10(7):. PubMed ID: 34359928
[TBL] [Abstract][Full Text] [Related]
11. Vasculogenic mimicry in carcinogenesis and clinical applications.
Luo Q; Wang J; Zhao W; Peng Z; Liu X; Li B; Zhang H; Shan B; Zhang C; Duan C
J Hematol Oncol; 2020 Mar; 13(1):19. PubMed ID: 32169087
[TBL] [Abstract][Full Text] [Related]
12. Generation of erythroid cells from polyploid giant cancer cells: re-thinking about tumor blood supply.
Yang Z; Yao H; Fei F; Li Y; Qu J; Li C; Zhang S
J Cancer Res Clin Oncol; 2018 Apr; 144(4):617-627. PubMed ID: 29417259
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia promotes vasculogenic mimicry formation by vascular endothelial growth factor A mediating epithelial-mesenchymal transition in salivary adenoid cystic carcinoma.
Wang HF; Wang SS; Zheng M; Dai LL; Wang K; Gao XL; Cao MX; Yu XH; Pang X; Zhang M; Wu JB; Wu JS; Yang X; Tang YJ; Chen Y; Tang YL; Liang XH
Cell Prolif; 2019 May; 52(3):e12600. PubMed ID: 30945361
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of compound DMBT on hypoxia-induced vasculogenic mimicry in human breast cancer.
Li S; Zhang Q; Zhou L; Guan Y; Chen S; Zhang Y; Han X
Biomed Pharmacother; 2017 Dec; 96():982-992. PubMed ID: 29208325
[TBL] [Abstract][Full Text] [Related]
15. Vasculogenic mimicry: a novel target for glioma therapy.
Chen YS; Chen ZP
Chin J Cancer; 2014 Feb; 33(2):74-9. PubMed ID: 23816560
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy checkpoints in ovarian cancer vasculogenic mimicry: Tumor immune microenvironments, and drugs.
Hu H; Ma T; Liu N; Hong H; Yu L; Lyu D; Meng X; Wang B; Jiang X
Int Immunopharmacol; 2022 Oct; 111():109116. PubMed ID: 35969899
[TBL] [Abstract][Full Text] [Related]
17. The relationship between vasculogenic mimicry and epithelial-mesenchymal transitions.
Liu Q; Qiao L; Liang N; Xie J; Zhang J; Deng G; Luo H; Zhang J
J Cell Mol Med; 2016 Sep; 20(9):1761-9. PubMed ID: 27027258
[TBL] [Abstract][Full Text] [Related]
18. Tumor cell vasculogenic mimicry: from controversy to therapeutic promise.
Seftor RE; Hess AR; Seftor EA; Kirschmann DA; Hardy KM; Margaryan NV; Hendrix MJ
Am J Pathol; 2012 Oct; 181(4):1115-25. PubMed ID: 22944600
[TBL] [Abstract][Full Text] [Related]
19. Vascular mimicry: Triggers, molecular interactions and in vivo models.
Wechman SL; Emdad L; Sarkar D; Das SK; Fisher PB
Adv Cancer Res; 2020; 148():27-67. PubMed ID: 32723566
[TBL] [Abstract][Full Text] [Related]
20. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
